Stocks and Investing
Stocks and Investing
Wed, April 22, 2020
[ Wed, Apr 22nd 2020
] - WOPRAI
[ Wed, Apr 22nd 2020
] - WOPRAI
[ Wed, Apr 22nd 2020
] - WOPRAI
[ Wed, Apr 22nd 2020
] - WOPRAI
[ Wed, Apr 22nd 2020
] - WOPRAI
[ Wed, Apr 22nd 2020
] - WOPRAI
[ Wed, Apr 22nd 2020
] - WOPRAI
[ Wed, Apr 22nd 2020
] - WOPRAI
[ Wed, Apr 22nd 2020
] - WOPRAI
[ Wed, Apr 22nd 2020
] - WOPRAI
[ Wed, Apr 22nd 2020
] - WOPRAI
[ Wed, Apr 22nd 2020
] - WOPRAI
[ Wed, Apr 22nd 2020
] - WOPRAI
Tue, April 21, 2020
[ Tue, Apr 21st 2020
] - WOPRAI
[ Tue, Apr 21st 2020
] - WOPRAI
[ Tue, Apr 21st 2020
] - WOPRAI
[ Tue, Apr 21st 2020
] - WOPRAI
[ Tue, Apr 21st 2020
] - WOPRAI
[ Tue, Apr 21st 2020
] - WOPRAI
[ Tue, Apr 21st 2020
] - WOPRAI
[ Tue, Apr 21st 2020
] - WOPRAI
[ Tue, Apr 21st 2020
] - WOPRAI
[ Tue, Apr 21st 2020
] - WOPRAI
[ Tue, Apr 21st 2020
] - WOPRAI
[ Tue, Apr 21st 2020
] - WOPRAI
[ Tue, Apr 21st 2020
] - WOPRAI
[ Tue, Apr 21st 2020
] - WOPRAI
[ Tue, Apr 21st 2020
] - WOPRAI
Evan Seigerman Maintained (VRTX) at Buy with Increased Target to $298 on, Apr 21st, 2020
Evan Seigerman of Credit Suisse, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Buy with Increased Target from $258 to $298 on, Apr 21st, 2020.
Evan has made no other calls on VRTX in the last 4 months.
There are 10 other peers that have a rating on VRTX. Out of the 10 peers that are also analyzing VRTX, 1 agrees with Evan's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Brian Skorney of "Baird" Downgraded from Buy to Hold and Increased Target to $230 on, Friday, January 31st, 2020
These are the ratings of the 9 analyists that currently disagree with Evan
- Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $258 on, Wednesday, April 15th, 2020
- Gena Wang of "Barclays" Initiated at Buy on, Friday, March 20th, 2020
- Alethia Young of "Cantor Fitzgerald" Reiterated at Buy with Increased Target to $275 on, Wednesday, March 11th, 2020
- Brian Abrahams of "RBC Capital" Maintained at Buy with Increased Target to $260 on, Friday, January 31st, 2020
- Paul Matteis of "Stifel" Maintained at Strong Buy with Increased Target to $275 on, Friday, January 31st, 2020
- Ying Huang of "B of A Securities" Maintained at Strong Buy with Increased Target to $295 on, Friday, January 31st, 2020
- Kevin Huang of "CFRA" Maintained at Strong Buy with Increased Target to $286 on, Friday, January 31st, 2020
- Hartaj Singh of "Oppenheimer" Maintained at Buy with Increased Target to $265 on, Wednesday, January 8th, 2020
- Edward Tenthoff of "Piper Sandler" Maintained at Buy with Increased Target to $284 on, Monday, January 6th, 2020
Contributing Sources
Similar Stocks and Investing Articles
[ Wed, Apr 15th 2020
] - WOPRAI
[ Wed, Apr 15th 2020
] - WOPRAI
[ Wed, Mar 11th 2020
] - WOPRAI
[ Thu, Mar 05th 2020
] - WOPRAI
[ Wed, Jan 08th 2020
] - WOPRAI
[ Wed, Nov 20th 2019
] - WOPRAI
[ Tue, Nov 19th 2019
] - WOPRAI
[ Tue, Oct 22nd 2019
] - WOPRAI
[ Thu, Oct 17th 2019
] - WOPRAI